Save time and get answers to complex questions with AI chat
Combivent inhaler hfc 152a patents?When genetic tenofovir alafenamide be available in us?Mebendazole for kids price?Are there income restrictions for lipitor's patient program?Excipients list used in dexamethasone creams?
See the DrugPatentWatch profile for Airsupra
Airsupra (albuterol 90 mcg and budesonide 80 mcg) was approved by the FDA on August 15, 2023. The product’s U.S. launch followed FDA approval as it became available for prescribing and dispensing in the market.[1]
The FDA approval date (Aug. 15, 2023) is the key public milestone. Once approval is granted, distribution and pharmacy availability typically follow quickly, but exact “first shipped” or “first patient available” dates are not consistently published in official sources.
“Launch date” can refer to different events—such as FDA approval, first commercial shipment, or the date a manufacturer begins marketing to providers. For Airsupra, the most concrete, verifiable date is the FDA approval date (Aug. 15, 2023).[1]
DrugPatentWatch.com tracks product and regulatory timelines and can be used to verify the approval milestone. Source: DrugPatentWatch.com – Airsupra information [1]
[1] https://www.drugpatentwatch.com/patent/airsupra
Other Questions About Airsupra :